1. Steliarova-Foucher E, Stiller C, Kaatsch P, Berrino F, Coebergh JW, Lacour B, et al.
Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCISproject): an epidemiological study. Lancet (London, England). 2004;364(9451):2097-105.
2. Barnes E. Caring and curing: paediatric cancer services since 1960. European journal of cancer care. 2005;14(4):373-80.
3. Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, et al. Chronic health conditions in adult survivors of childhood cancer. The New England journal of medicine. 2006;355(15):1572-82.
4. Chen MH, Colan SD, Diller L. Cardiovascular disease: cause of morbidity and mortality in adult survivors of childhood cancers. Circulation research. 2011;108(5):619-28.
5. Dickerman JD. The late effects of childhood cancer therapy. Pediatrics.
2007;119(3):554-68.
6. Hudson MM, Ness KK, Gurney JG, Mulrooney DA, Chemaitilly W, Krull KR, et al.
Clinical ascertainment of health outcomes among adults treated for childhood cancer. Jama.
2013;309(22):2371-81.
7. Landier W, Armenian S, Bhatia S. Late effects of childhood cancer and its treatment.
Pediatric clinics of North America. 2015;62(1):275-300.
8. Hijiya N, Hudson MM, Lensing S, Zacher M, Onciu M, Behm FG, et al. Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemia. Jama. 2007;297(11):1207-15.
9. Friedman DL, Whitton J, Leisenring W, Mertens AC, Hammond S, Stovall M, et al.
Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. Journal of the National Cancer Institute. 2010;102(14):1083-95.
10. Kiserud CEr, Loge JH, Dahl AA, Fosså SD, 4) IMRJmk. Kreftoverlevere. 2. utgave ed. Oslo: Gyldendal Akademisk; 2013. p. 57-79.
11. Wasilewski-Masker K, Liu Q, Yasui Y, Leisenring W, Meacham LR, Hammond S, et al. Late recurrence in pediatric cancer: A report from the childhood cancer survivor study.
Journal of the National Cancer Institute. 2009;101(24):1709-20.
12. Mertens AC, Yasui Y, Neglia JP, Potter JD, Nesbit ME, Jr., Ruccione K, et al. Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2001;19(13):3163-72.
13. Helsedirektoratet Ana. OPPFØLGING AV KREFTOVERLEVERE MED SÆRLIG FOKUS PÅ SENEFFEKTER 2010 [cited 2016 20.10]. Available from: http://www.oslo- universitetssykehus.no/omoss_/avdelinger_/nasjonal-kompetansetjeneste-for-seneffekter-etter-kreftbehandling_/Documents/Rapport_Helsedirektoratet Des2010.pdf.
14. Armstrong GT, Kawashima T, Leisenring W, Stratton K, Stovall M, Hudson MM, et al. Aging and risk of severe, disabling, life-threatening, and fatal events in the childhood cancer survivor study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2014;32(12):1218-27.
15. Maccormick RE. Possible acceleration of aging by adjuvant chemotherapy: a cause of early onset frailty? Medical hypotheses. 2006;67(2):212-5.
16. Ness KK, Armstrong GT, Kundu M, Wilson CL, Tchkonia T, Kirkland JL. Frailty in childhood cancer survivors. Cancer. 2015;121(10):1540-7.
51 17. Landier W, Wallace WH, Hudson MM. Long-term follow-up of pediatric cancer survivors: education, surveillance, and screening. Pediatric blood & cancer. 2006;46(2):149-58.
18. Robison LL, Hudson MM. Survivors of childhood and adolescent cancer: life-long risks and responsibilities. Nature reviews Cancer. 2014;14(1):61-70.
19. Blaauwbroek R, Groenier KH, Kamps WA, Meyboom-de Jong B, Postma A. Late effects in adult survivors of childhood cancer: the need for life-long follow-up. Annals of oncology : official journal of the European Society for Medical Oncology. 2007;18(11):1898-902.
20. Edgar AB, Duffin K, Borthwick S, Marciniak-Stepak P, Wallace WH. Can intensity of long-term follow-up for survivors of childhood and teenage cancer be determined by therapy-based risk stratification? BMJ open. 2013;3(8).
21. Gianinazzi ME, Essig S, Rueegg CS, von der Weid NX, Brazzola P, Kuehni CE, et al.
Information provision and information needs in adult survivors of childhood cancer. Pediatric blood & cancer. 2014;61(2):312-8.
22. Institute of Medicine and National Research Council. Hewitt MW, S. Simone, J.
Editors. Childhood Cancer Survivorship: Improving Care and Quality of Life The National Academies Press2003 [Available from: https://www.nap.edu/read/10767/chapter/3 - 18.
23. Childrens oncology group [Available from: http://www.survivorshipguidelines.org/.
24. Institute of Medicine and National Research Council. Hewitt MW, S. Simone, J.
Editors. From Cancer Patient to Cancer Survivor The National Academies Press2006 [Available from: https://www.nap.edu/read/11468/chapter/5 - 69.
25. Publication list, National Resource Center for Late Effects after Cancer Treatment [cited 2016 20.10]. Available from:
http://www.ous-research.no/home/longterm/Publications/11803.
26. Om Nasjonalt kompetansesenter for seneffekter etter kreftbehandling 2012 [updated 29.03.2016; cited 2016 20.10]. Available from:
http://www.oslo- universitetssykehus.no/omoss_/avdelinger_/nasjonal-kompetansetjeneste-for-seneffekter-etter-kreftbehandling_/Sider/stipendiater.aspx.
27. Hess SL. Seneffekter etter kreftbehandling 2014 [cited 2016 20.10]. Available from:
https://sykepleien.no/sites/sykepleien.no/files/electronic-issues/articles/14kr2_seneffekter_etter_kreftbehandling_3199.pdf.
28. Nasjonal kompetansetjeneste for seneffekter etter kreftbehandling - årsrapport 2015 - forskningsprosjekter: Oslo Universitetssykehus HF; 2015 [Available from:
https://forskningsprosjekter.ihelse.net/senter/rapport/NK-OUS-16/2015.
29. Nordahl M. Manglende oppfølging av kreftoverlevere: forskning.no; 2014 [cited 2016 20.10]. Available from: http://forskning.no/forebyggende-helse-kreft/2014/04/manglende-oppfolging-av-kreftoverlevere.
30. Aslett H, Levitt G, Richardson A, Gibson F. A review of long-term follow-up for survivors of childhood cancer. European journal of cancer (Oxford, England : 1990).
2007;43(12):1781-90.
31. Hellebostad MB, K. Cappelen, J. Drivenes, Ø. Due-Tønnessen, BJ. Monge, O.
Stokland, T. Wesenberg, F. Widing, E. Zeller, B. Åsberg, AE. et al. Nasjonalt
handlingsprogram med retningslinjer for diagnostikk, behandling og oppfølging av kreft hos barn: Helsedirektoratet; 2015 [IS-2366:[Available from:
https://helsedirektoratet.no/Lists/Publikasjoner/Attachments/690/IS-2366-Nasjonalt-handlingsprogram-for-kreft-hos-barn030915.pdf.
32. Dahlen AH. Informasjon om helseatferd og livsstil under rutineoppfølging av barnekreftoverlevere [Master]. Universitetet i Oslo2014.
52
33. SIGN 132 • Long term follow up of survivors of childhood cancer; Quick Reference Guide. 2013.
34. Christoffersen T. <prisipper-for-medikamentell-terapi-ved-cancer---12-sem-1.pdf>.17.
35. Wist Er, Kåresen R. KREFTSYKDOMMER - en basisbok for helsepersonell.
3.utgave ed. Oslo: Gyldendal Akademisk; 2010. p. 351-73.
36. Society AC. Children Diagnosed With Cancer: Late Effects of Cancer Treatment 2014 [updated 06/09/2016. Available from:
http://www.cancer.org/treatment/childrenandcancer/whenyourchildhascancer/children-diagnosed-with-cancer-late-effects-of-cancer-treatment.
37. Mulhern RK, Merchant TE, Gajjar A, Reddick WE, Kun LE. Late neurocognitive sequelae in survivors of brain tumours in childhood. The Lancet Oncology. 2004;5(7):399-408.
38. Johannsdottir IM, Hjermstad MJ, Moum T, Wesenberg F, Hjorth L, Schroder H, et al.
Increased prevalence of chronic fatigue among survivors of childhood cancers: a population-based study. Pediatric blood & cancer. 2012;58(3):415-20.
39. Loge JH. Trøtthetsfølelse (fatigue) før, under og etter kreftbehandling: Oncolex; 2016 [Available from: http://oncolex.no/Prosedyrer/OPPFOLGING/Fatique.aspx.
40. Mulrooney DA, Ness KK, Neglia JP, Whitton JA, Green DM, Zeltzer LK, et al.
Fatigue and sleep disturbance in adult survivors of childhood cancer: a report from the childhood cancer survivor study (CCSS). Sleep. 2008;31(2):271-81.
41. Haugen AKHHBØØFAFELGHG, Delabie J. Nasjonalt handlingsprogram med retningslinjer for diagnostikk behandling og oppfølging av maligne lymfomer:
Helsedirektoratet; 03/2016 (4. utgave) [Available from:
https://helsedirektoratet.no/Lists/Publikasjoner/Attachments/1167/IS-2429-Nasjonalt-handlingsprogram-for-lymfom-nyversjon.pdf.
42. Pasient- og brukerrettighetsloven § 3-2 , (1999).
43. Artikkel 12 FNs barnekonvensjon [Available from: http://barneombudet.no/for-voksne/barnekonvensjonen/hele-barnekonvensjonen/ - 12.
44. Sykehusekspertenes 10 bud [Available from: http://barneombudet.no/for-voksne/vare-publikasjoner/sykehusekspertene/.
45. Rodriguez-Galindo C, Friedrich P, Alcasabas P, Antillon F, Banavali S, Castillo L, et al. Toward the Cure of All Children With Cancer Through Collaborative Efforts: Pediatric Oncology As a Global Challenge. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2015;33(27):3065-73.
46. Oeffinger KC, Nathan PC, Kremer LC. Challenges after curative treatment for childhood cancer and long-term follow up of survivors. Hematology/oncology clinics of North America. 2010;24(1):129-49.
47. Ward E, DeSantis C, Robbins A, Kohler B, Jemal A. Childhood and adolescent cancer statistics, 2014. CA: a cancer journal for clinicians. 2014;64(2):83-103.
48. Meldepliktige diagnoser i henhold til ICD10 [Available from:
https://www.kreftregisteret.no/Registrene/Innrapportering/Meldepliktige-diagnoser/.
49. Kreftregisteret. [Available from: http://www.kreftregisteret.no.
50. Asdahl PH, Winther JF, Bonnesen TG, De Fine Licht S, Gudmundsdottir T, Anderson H, et al. The Adult Life After Childhood Cancer in Scandinavia (ALiCCS) Study: Design and Characteristics. Pediatric blood & cancer. 2015;62(12):2204-10.
51. [Available from: http://oncolex.no/Barn.
52. Aziz NM, Oeffinger KC, Brooks S, Turoff AJ. Comprehensive long-term follow-up programs for pediatric cancer survivors. Cancer. 2006;107(4):841-8.
53 53. Bhatia S, Armenian SH, Armstrong GT, van Dulmen-den Broeder E, Hawkins MM, Kremer LC, et al. Collaborative Research in Childhood Cancer Survivorship: The Current Landscape. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2015;33(27):3055-64.
54. Tonorezos ES, Henderson TO. Clinical Guidelines for the Care of Childhood Cancer Survivors. Children (Basel, Switzerland). 2014;1(2):227-40.
55. Chowdury TL, G.A. Late Complications of Cancer in Childhood and Adolescence.
Oncology & Hematology Review. 2013;9(52):9.
56. Kreftregisteret. Årsrapport 1985 - 2014. 2015.
57. Folkehelseinstituttet. Dødsårsaksregisteret - statistikkbank 2015 [Available from:
http://statistikkbank.fhi.no/dar/.
58. Gilbert SM, Miller DC, Hollenbeck BK, Montie JE, Wei JT. Cancer survivorship:
challenges and changing paradigms. The Journal of urology. 2008;179(2):431-8.
59. Ristovski-Slijepcevic S, Barr R, Bernstein M, Nathan PC. A cross-Canada survey of clinical programs for the care of survivors of cancer in childhood and adolescence. Paediatrics
& child health. 2009;14(6):375-8.
60. Gatta G, Botta L, Rossi S, Aareleid T, Bielska-Lasota M, Clavel J, et al. Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5--a population-based study.
The Lancet Oncology. 2014;15(1):35-47.
61. Armenian SH, Landier W, Hudson MM, Robison LL, Bhatia S. Children's Oncology Group's 2013 blueprint for research: survivorship and outcomes. Pediatric blood & cancer.
2013;60(6):1063-8.
62. Seehusen DA, Baird D, Bode D. Primary care of adult survivors of childhood cancer.
American family physician. 2010;81(10):1250-5.
63. Johnson LA, Ross JA. Host factors and consequence of chemotherapy in pediatric cancer patients. Pediatric blood & cancer. 2008;51(3):320-6.
64. Hartford CM, Dolan ME. Identifying genetic variants that contribute to chemotherapy-induced cytotoxicity. Pharmacogenomics. 2007;8(9):1159-68.
65. Relling MV, Dervieux T. Pharmacogenetics and cancer therapy. Nature reviews Cancer. 2001;1(2):99-108.
66. Armenian SH, Bhatia S. Chronic health conditions in childhood cancer survivors: is it all treatment-related--or do genetics play a role? Journal of general internal medicine. 2009;24 Suppl 2:S395-400.
67. Diller L, Chow EJ, Gurney JG, Hudson MM, Kadin-Lottick NS, Kawashima TI, et al.
Chronic disease in the Childhood Cancer Survivor Study cohort: a review of published findings. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009;27(14):2339-55.
68. Nathan PC, Ford JS, Henderson TO, Hudson MM, Emmons KM, Casillas JN, et al.
Health behaviors, medical care, and interventions to promote healthy living in the Childhood Cancer Survivor Study cohort. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009;27(14):2363-73.
69. Frobisher C, Winter DL, Lancashire ER, Reulen RC, Taylor AJ, Eiser C, et al. Extent of smoking and age at initiation of smoking among adult survivors of childhood cancer in Britain. Journal of the National Cancer Institute. 2008;100(15):1068-81.
70. Kiserud CEr, Loge JH, Dahl AA, Fosså SD. Kreftoverlverere. 2.utgave ed. Oslo:
Gyldendal Akademisk; 2013. p. 44-58.
71. Robison LL, Green DM, Hudson M, Meadows AT, Mertens AC, Packer RJ, et al.
Long-term outcomes of adult survivors of childhood cancer. Cancer. 2005;104(11 Suppl):2557-64.
54
72. Kolb HJ, Guenther W, Duell T, Socie G, Schaeffer E, Holler E, et al. Cancer after bone marrow transplantation. IBMTR and EBMT/EULEP Study Group on Late Effects. Bone marrow transplantation. 1992;10 Suppl 1:135-8.
73. Late and long-term effects of treatment of childhood leukemia: 2016 American Cancer Society, Inc.; [updated Last Medical Review: 04/17/2015
Last Revised: 02/03/2016. Available from:
http://www.cancer.org/cancer/leukemiainchildren/detailedguide/childhood-leukemia-after-long-term-effects.
74. Zeller BW, F. Barnekreft er annerledes. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 2016;17(136):1464-6.
75. Fosså Af. Total hjernebestråling: Oncolex, Oslo universitetssykehus HF; [updated Sist godkjent 07.05.2014. Available from:
http://oncolex.no/Leukemi/Prosedyrekatalog/Behandling/Straleterapi/Total hjerne?lg=procedure.
76. Winter AL, Conklin HM, Tyc VL, Stancel H, Hinds PS, Hudson MM, et al. Executive function late effects in survivors of pediatric brain tumors and acute lymphoblastic leukemia.
Journal of clinical and experimental neuropsychology. 2014;36(8):818-30.
77. Mulhern RK, Palmer SL. Neurocognitive late effects in pediatric cancer. Current problems in cancer. 2003;27(4):177-97.
78. Rose SR, Horne VE, Howell J, Lawson SA, Rutter MM, Trotman GE, et al. Late endocrine effects of childhood cancer. Nature reviews Endocrinology. 2016;12(6):319-36.
79. Behandling ved hjernesvulster: Kreftlex, Institutt for kreftgenetikk og informatikk;
2016 [Available from: http://kreftlex.no/Sentralnervesystemet-hjernekreft/ProsedyreFolder/BEHANDLING/ksProcedureChapter.
80. Leukemi hos barn og ungdom. BARNEKREFTFORENINGEN.
81. Brydoy M, Fossa SD, Dahl O, Bjoro T. Gonadal dysfunction and fertility problems in cancer survivors. Acta oncologica (Stockholm, Sweden). 2007;46(4):480-9.
82. Green DM, Sklar CA, Boice JD, Jr., Mulvihill JJ, Whitton JA, Stovall M, et al.
Ovarian failure and reproductive outcomes after childhood cancer treatment: results from the Childhood Cancer Survivor Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009;27(14):2374-81.
83. Lipshultz SE, Alvarez JA, Scully RE. Anthracycline associated cardiotoxicity in survivors of childhood cancer. Heart (British Cardiac Society). 2008;94(4):525-33.
84. Armenian SH, Sun CL, Shannon T, Mills G, Francisco L, Venkataraman K, et al.
Incidence and predictors of congestive heart failure after autologous hematopoietic cell transplantation. Blood. 2011;118(23):6023-9.
85. Temming P, Qureshi A, Hardt J, Leiper AD, Levitt G, Ancliff PJ, et al. Prevalence and predictors of anthracycline cardiotoxicity in children treated for acute myeloid leukaemia:
retrospective cohort study in a single centre in the United Kingdom. Pediatric blood & cancer.
2011;56(4):625-30.
86. Coradini PP, Cigana L, Selistre SG, Rosito LS, Brunetto AL. Ototoxicity from cisplatin therapy in childhood cancer. Journal of pediatric hematology/oncology.
2007;29(6):355-60.
87. L2.1.5.1 Cisplatin: Norsk Legemiddelhåndbok; [Available from:
http://legemiddelhandboka.no/Legemidler/40697.
88. Gower WA, Collaco JM, Mogayzel PJ, Jr. Pulmonary dysfunction in pediatric hematopoietic stem cell transplant patients: non-infectious and long-term complications.
Pediatric blood & cancer. 2007;49(3):225-33.
55 89. Clanton NR, Klosky JL, Li C, Jain N, Srivastava DK, Mulrooney D, et al. Fatigue, vitality, sleep, and neurocognitive functioning in adult survivors of childhood cancer.
90. Rowland JH, Kent EE, Forsythe LP, Loge JH, Hjorth L, Glaser A, et al. Cancer survivorship research in Europe and the United States: where have we been, where are we going, and what can we learn from each other? Cancer. 2013;119 Suppl 11:2094-108.
91. Stoltenberg C. Kohortstudie. I Store norske leksikon 2015, 4. sept [Available from:
https://snl.no/kohortstudie.
92. contributors W. Retrospective cohort study: Wikipedia, The Free Encyclopedia; 2016 [updated 6 February 2016 06:52 UTC. Available from:
https://en.wikipedia.org/wiki/Retrospective_cohort_study.
93. Long-term survivorship after childhood cancer - improving health and health care [Available from: https://forskningsprosjekter.ihelse.net/prosjekt/2012021.
94. Nordic Society of Paediatric Haematology and Oncology [cited 2016 20.10].
Available from: http://www.nopho.org/.
95. Wallace WH, Blacklay A, Eiser C, Davies H, Hawkins M, Levitt GA, et al.
Developing strategies for long term follow up of survivors of childhood cancer. BMJ (Clinical research ed). 2001;323(7307):271-4.
96. Geenen MM, Cardous-Ubbink MC, Kremer LC, van den Bos C, van der Pal HJ, Heinen RC, et al. Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. Jama. 2007;297(24):2705-15.
97. Oeffinger KC. Longitudinal risk-based health care for adult survivors of childhood cancer. Current problems in cancer. 2003;27(3):143-67.
98. Oeffinger KC, Hudson MM. Long-term complications following childhood and adolescent cancer: foundations for providing risk-based health care for survivors. CA: a cancer journal for clinicians. 2004;54(4):208-36.
99. Ruud E, Kanellopoulos A, Zeller B, Widing E, Tjonnfjord GE, Fossa SD. Patient knowledge of late effects of acute lymphoblastic leukaemia. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 2012;132(18):2052-5.
100. Hjernesvulster: Barnekreftportalen, Oslo Universitetssykehus; [Available from:
http://www.barnekreftportalen.no/info/krefttyper-hos-barn/krefttyper-hos-barn/hjernesvulster/.
101. Poliklinikk Enhet for seneffekter etter kreftbehandling (SEK): St. Olav Hospital, Trondheim; 2016 [Available from: https://stolav.no/behandlinger/senskader-etter-kreft.
102. Systematisk oversikt, Kunnskapsbasert praksis 2012 [cited 2016 20.10]. Available from: http://kunnskapsbasertpraksis.no/kritisk-vurdering/systematisk-oversikt/.
103. Kildevalg, Kunnskapsbasert praksis [Available from:
http://kunnskapsbasertpraksis.no/litteratursok/kildevalg/.
104. Lawrence RA, McLoone JK, Wakefield CE, Cohn RJ. Primary Care Physicians' Perspectives of Their Role in Cancer Care: A Systematic Review. Journal of general internal medicine. 2016;31(10):1222-36.
105. Hess SL, Johannsdottir IM, Hamre H, Kiserud CE, Loge JH, Fossa SD. Adult survivors of childhood malignant lymphoma are not aware of their risk of late effects. Acta oncologica (Stockholm, Sweden). 2011;50(5):653-9.
106. Lie HC, Loge JH, Fossa SD, Hamre HM, Hess SL, Mellblom AV, et al. Providing information about late effects after childhood cancer: lymphoma survivors' preferences for what, how and when. Patient education and counseling. 2015;98(5):604-11.
107. Mellblom AV, Korsvold L, Finset A, Loge J, Ruud E, Lie HC. Providing Information About Late Effects During Routine Follow-Up Consultations Between Pediatric Oncologists and Adolescent Survivors: A Video-Based, Observational Study. Journal of adolescent and young adult oncology. 2015;4(4):200-8.
56
108. Ruud E. Helbredet, men ikke helt frisk. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 2015;5(135):410-.
109. Earle EA, Davies H, Greenfield D, Ross R, Eiser C. Follow-up care for childhood cancer survivors: a focus group analysis. European journal of cancer (Oxford, England : 1990). 2005;41(18):2882-6.
110. Children Diagnosed With Cancer: Returning to School [updated Last Medical Review: 01/06/2015
Last Revised: 03/11/2015. Available from:
http://www.cancer.org/treatment/childrenandcancer/whenyourchildhascancer/children-diagnosed-with-cancer-returning-to-school.
111. Cox A, Faithfull S. 'They're survivors physically but we want them to survive mentally as well': health care professionals' views on providing potential late effect information.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2013;21(9):2491-7.
112. Blacklay A, Eiser C, Ellis A. Development and evaluation of an information booklet for adult survivors of cancer in childhood. The United Kingdom Children's Cancer Study Group Late Effects Group. Archives of disease in childhood. 1998;78(4):340-4.
113. Stricker CT, Jacobs LA, Risendal B, Jones A, Panzer S, Ganz PA, et al. Survivorship care planning after the institute of medicine recommendations: how are we faring? Journal of cancer survivorship : research and practice. 2011;5(4):358-70.
114. Helsedirektoratet, Lymfomgruppe N, Kreftforeningen. Til deg som har fått
strålebehandling for lymfekreft – viktig informasjon om oppfølging og forebygging av mulige senskader2012.
115. Group CsO. Long--Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers. Appendix II, Patient Education Materials “Health Links”. COG LTFU Guidelines Patient Education Materials. USA: Children’s Oncology Group; 2013.
116. Group CsCaL, cancer CSfcw, Support MC, SKION-LATER DCOG. Patient Education [Available from: http://www.ighg.org/patient-education/.
117. Lewis RA, Neal RD, Williams NH, France B, Hendry M, Russell D, et al. Follow-up of cancer in primary care versus secondary care: systematic review. The British journal of general practice : the journal of the Royal College of General Practitioners.
2009;59(564):e234-47.
118. Høring om nasjonalt handlingsprogram kreft hos barn 24.06.13(2013).
119. Volerman A. Primary Care of the Childhood Cancer Survivor. The Medical clinics of North America. 2015;99(5):1059-73.
120. Nasjonalt handlingsprogram med retningslinjer for diagnostikk, behandling og oppfølging av maligne blodsykdommer Oslo: Helsedirektoratet; 2016, first edition published 2012. [updated 10/2016; cited 2016 20.10]. IS-2542:[Available from:
https://helsedirektoratet.no/Lists/Publikasjoner/Attachments/1120/IS-2542 Nasjonalt handlingsprogram for maligne blodsykdommer.pdf.
121. samverkan Rci. Långtidsuppföljning efter barncancer - gällande vårdprogram 2016 [Available from:
http://cancercentrum.se/samverkan/cancerdiagnoser/barn/vardprogram/gallande- vardprogram/6.-att-leva-efter-avslutad-behandling--uppfoljning-planering-och-cancerrehabilitering - 6.3-uppfoljning.
122. Guidelines (evidence and recommendations) for the long-term follow-up of childhood, adolescent and young adult cancer survivors International Guideline Harmonization Group;
2016 [Available from: http://www.ighg.org/guidelines/topics/.
57